I
Inga Clausen
Researcher at Hoffmann-La Roche
Publications - 2
Citations - 136
Inga Clausen is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Circulating tumor cell. The author has an hindex of 2, co-authored 2 publications receiving 124 citations.
Papers
More filters
Journal ArticleDOI
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.
Jordan Madic,Jordan Madic,Anna Kiialainen,François-Clément Bidard,Fabian Birzele,Guillemette Ramey,Quentin Leroy,Thomas Rio Frio,Isabelle Vaucher,Virginie Raynal,Virginie Bernard,Alban Lermine,Inga Clausen,Nicolas Giroud,Roland Schmucki,Maud Milder,Maud Milder,Carsten Horn,Olivia Spleiss,Olivier Lantz,Olivier Lantz,Marc-Henri Stern,Marc-Henri Stern,Jean-Yves Pierga,Jean-Yves Pierga,Martin Weisser,Ronald Lebofsky +26 more
TL;DR: In this article, the authors used the high prevalence of TP53 mutations in triple negative breast cancer (TNBC) to compare ctDNA and CTC detection rates and prognostic value in metastatic TNBC patients.
Proceedings ArticleDOI
Abstract PD3-8: Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
François-Clément Bidard,Jordan Madic,Anna Kiialainen,Fabian Birzele,Guillemette Ramey,Quentin Leroy,Thomas Rio Frio,Virginie Raynal,Virginie Bernard,Alban Lermine,Inga Clausen,Nicolas Giroud,Roland Schmucki,Carsten Horn,Olivia Spleiss,Olivier Lantz,Marc-Henri Stern,Martin Weisser,Ronald Lebofsky,Jean-Yves Pierga +19 more
TL;DR: Demonstrating a good sensitivity (81%), ctDNA by the TAm-Seq is more frequently detected than CTCs in the 27 TNMBC with TP53 mutations, and the observed correlation between the 2 massively parallel sequencing approaches suggested that ct DNA levels data were quantitative.